Table 12.
Performance of estimated BA for subjects with different chronic diseases using different DL models. Results are shown for BA acceleration (
) estimated using anthropometric data and blood biomarkers, respectively
| DNN (anthropometry) | CNN (anthropometry) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diabetes | Kidney | CVD | All | Others | Diabetes | Kidney | CVD | All | Others | |
| Average | –0.96 | –0.73 | –0.67 | –0.01 | 0.20 | –4.89 | –4.58 | –2.62 | –0.82 | –0.18 |
| Positive | 0.66 | 0.81 | 0.60 | 0.78 | 0.81 | 8.34 | 8.24 | 8.39 | 8.90 | 9.05 |
| Negative | –1.69 | –1.78 | –1.64 | –1.54 | –1.45 | –12.49 | –12.90 | –11.16 | –10.55 | –10.22 |
| % Pos | 30.86 | 40.67 | 43.26 | 65.98 | 73.36 | 36.51 | 39.33 | 43.68 | 50.02 | 52.07 |
| % Neg | 69.14 | 59.33 | 56.74 | 34.02 | 26.64 | 63.49 | 60.67 | 56.32 | 49.98 | 47.93 |
| DNN (biomarkers) | CNN (biomarkers) | |||||||||
| Diabetes | Kidney | CVD | All | Others | Diabetes | Kidney | CVD | All | Others | |
| Average | –4.42 | –3.67 | –2.91 | 0.29 | 1.32 | –12.79 | –25.10 | –4.97 | –0.96 | 0.86 |
| Positive | 2.73 | 4.39 | 3.14 | 4.65 | 4.83 | 9.33 | 11.24 | 11.47 | 12.24 | 12.45 |
| Negative | –5.47 | –6.03 | –5.05 | –4.54 | –4.19 | –20.12 | –35.75 | –16.51 | –14.04 | –12.50 |
| % Pos | 12.87 | 22.67 | 26.11 | 52.51 | 61.09 | 24.87 | 22.67 | 41.26 | 49.77 | 53.54 |
| % Neg | 87.13 | 77.33 | 73.89 | 47.49 | 38.91 | 75.13 | 77.33 | 58.74 | 50.23 | 46.46 |